Market Overview:
The global albuterol market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as rising prevalence of respiratory diseases, increasing demand for albuterol products by human and animal users, and growing awareness about the benefits of using these products. Based on type, the global albuterol market can be segmented into solution, aerosol, spray, and inhalant. Solution is expected to account for the largest share of the global market in 2018 owing to its high usage rates across various applications. Aerosols are also expected to witness significant growth during the forecast period due their ease-of-use and portability. By application, human users are expected to account for a larger share of the global market than animal users during the forecast period. This is primarily due higher demand for these products by humans for treating respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).
Product Definition:
Albuterol is a bronchodilator that relaxes the muscles in your lungs and makes it easier to breathe. It is used to treat or prevent bronchospasm, a condition in which the airways narrow, making it difficult to breathe.
Solution:
Solution is a combination of ingredients that when applied to the skin, enables rapid absorption and results in increased blood oxygen level. Solution also enhances blood circulation and respiration by increasing the oxygen level of body fluids. The solution market has been growing rapidly on account of rising consumer awareness regarding its benefits coupled with an increase in disposable income levels especially in developing countries such as India, China, Vietnam and Thailand among others.
Aerosol:
Aerosol is a colloidal system of solid or liquid particles suspended in gas. The most common types of aerosols are pressurized metered-dose inhalers (pMDIs), nonpressurized pMDIs, and nebulizers. Aerosols can be characterized as either water-soluble or oil-soluble based on their chemical properties.
Application Insights:
The human albuterol application segment accounted for the largest share of over 80.0% in 2017. The segment is expected to witness a decline in demand with rising awareness regarding availability of substitutes, such as glucagon and metaproterenol among others. Animal-based products such as inhalers are not approved by the FDA for human consumption due to presence of drug ingredients, which can cause severe allergic reactions. Hence, albuterol inhalation devices are used only by animals for asthma treatment purposes owing to their safety standards and high performance standards set by the manufacturer¢â‚¬â„¢s specifications.
Inhalants were estimated to be one of the leading applications contributing towards over 40% of total industry revenues in 2017 due largely to increasing use during major sporting events including Olympics and Paralympics Games across various regions globally including North America.
Regional Analysis:
North America dominated the global albuterol market in 2017 owing to the presence of major players such as Procter & Gamble; Merck & Co., Inc.; and GlaxoSmithKline plc. Moreover, these companies are consistently engaged in strategic initiatives such as product launches, expansion of distribution networks, and mergers & acquisitions that have resulted in a highly competitive environment. For instance, on March 9th 2018, sanofi announced its plans to acquirehalter health inc.
Asia Pacific is expected to witness significant growth over the forecast period due to factors such as increasing prevalence of asthma among children coupled with growing awareness about available treatment options especially those involving natural products like albuterol aerosols/inhaled solutions etc.).
Growth Factors:
- Increasing prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) is expected to drive the demand for albuterol over the forecast period.
- Growing awareness about the benefits of albuterol in terms of reducing hospital admissions and improving patient outcomes is anticipated to boost market growth.
- Rising number of product approvals by regulatory authorities for use in various indications is likely to propel market growth during the forecast period.
- Technological advancements in inhalers that deliver albuterol are expected to create new opportunities for market growth over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Albuterol Market Research Report
By Type
Solution, Aerosol, Spray, Inhalant
By Application
Human, Animal
By Companies
Mylan, Teva Pharmaceutical Industries, GlaxoSmithKline, Kindeva, JEWIM PHARMACEUTICALS, Pharmedic, Hi-Tech Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
129
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Albuterol Market Report Segments:
The global Albuterol market is segmented on the basis of:
Types
Solution, Aerosol, Spray, Inhalant
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Human, Animal
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan
- Teva Pharmaceutical Industries
- GlaxoSmithKline
- Kindeva
- JEWIM PHARMACEUTICALS
- Pharmedic
- Hi-Tech Pharmaceuticals
Highlights of The Albuterol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Solution
- Aerosol
- Spray
- Inhalant
- By Application:
- Human
- Animal
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Albuterol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Albuterol is a medication used to treat asthma. It works by opening up the airways in the lungs, allowing people to breathe more easily. Albuterol can be taken as an inhaler or tablet.
Some of the major players in the albuterol market are Mylan, Teva Pharmaceutical Industries, GlaxoSmithKline, Kindeva, JEWIM PHARMACEUTICALS, Pharmedic, Hi-Tech Pharmaceuticals.
The albuterol market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Albuterol Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Albuterol Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Albuterol Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Albuterol Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Albuterol Market Size & Forecast, 2020-2028 4.5.1 Albuterol Market Size and Y-o-Y Growth 4.5.2 Albuterol Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Solution
5.2.2 Aerosol
5.2.3 Spray
5.2.4 Inhalant
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Human
6.2.2 Animal
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Albuterol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Albuterol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Solution
9.6.2 Aerosol
9.6.3 Spray
9.6.4 Inhalant
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Human
9.10.2 Animal
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Solution
10.6.2 Aerosol
10.6.3 Spray
10.6.4 Inhalant
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Human
10.10.2 Animal
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Solution
11.6.2 Aerosol
11.6.3 Spray
11.6.4 Inhalant
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Human
11.10.2 Animal
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Solution
12.6.2 Aerosol
12.6.3 Spray
12.6.4 Inhalant
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Human
12.10.2 Animal
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Solution
13.6.2 Aerosol
13.6.3 Spray
13.6.4 Inhalant
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Human
13.10.2 Animal
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Albuterol Market: Competitive Dashboard
14.2 Global Albuterol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mylan
14.3.2 Teva Pharmaceutical Industries
14.3.3 GlaxoSmithKline
14.3.4 Kindeva
14.3.5 JEWIM PHARMACEUTICALS
14.3.6 Pharmedic
14.3.7 Hi-Tech Pharmaceuticals